Cargando…
Cardiovascular magnetic resonance in light-chain amyloidosis to guide treatment
AIMS: To assess the ability of cardiovascular magnetic resonance (CMR) to (i) measure changes in response to chemotherapy; (ii) assess the correlation between haematological response and changes in extracellular volume (ECV); and (iii) assess the association between changes in ECV and prognosis over...
Autores principales: | Martinez-Naharro, Ana, Patel, Rishi, Kotecha, Tushar, Karia, Nina, Ioannou, Adam, Petrie, Aviva, Chacko, Liza A, Razvi, Yousuf, Ravichandran, Sriram, Brown, James, Law, Steven, Quarta, Cristina, Mahmood, Shameem, Wisniowski, Brendan, Pica, Silvia, Sachchithanantham, Sajitha, Lachmann, Helen J, Moon, James C, Knight, Daniel S, Whelan, Carol, Venneri, Lucia, Xue, Hui, Kellman, Peter, Gillmore, Julian D, Hawkins, Philip N, Wechalekar, Ashutosh D, Fontana, Marianna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9712028/ https://www.ncbi.nlm.nih.gov/pubmed/36239754 http://dx.doi.org/10.1093/eurheartj/ehac363 |
Ejemplares similares
-
Impact of early response on outcomes in AL amyloidosis following treatment with frontline Bortezomib
por: Ravichandran, Sriram, et al.
Publicado: (2021) -
The impact and importance of achieving a complete haematological response prior to renal transplantation in AL amyloidosis
por: Cohen, Oliver C., et al.
Publicado: (2020) -
Sex differences among patients with transthyretin amyloid cardiomyopathy – from diagnosis to prognosis
por: Patel, Rishi K., et al.
Publicado: (2022) -
(99m)Tc-DPD scintigraphy in immunoglobulin light chain (AL) cardiac amyloidosis
por: Quarta, Candida Cristina, et al.
Publicado: (2021) -
Cardiac biomarkers are prognostic in systemic light chain amyloidosis with no cardiac involvement by standard criteria
por: Sharpley, Faye A., et al.
Publicado: (2020)